Madrigal Pharmaceuticals, Inc. (MDGL)

Healthcare · Biotechnology · NASDAQ

Madrigal Pharmaceuticals, Inc. (MDGL) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $11.78B and a free-cash-flow yield of -1.7%. Over the most recent reported fiscal year, revenue grew 432.1%.

Market cap	$11.78B
Trailing P/E	—
FCF yield	-1.7%
Revenue growth (YoY)	+432.1%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live MDGL data on Nama Insights →